Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE
· Real-Time Price · USD
8.29
0.11 (1.34%)
At close: Sep 05, 2025, 3:59 PM
8.46
2.11%
After-hours: Sep 05, 2025, 07:18 PM EDT
Wave Life Sciences Revenue Breakdown
| Period Ending | Jun 30, 2021 |
|---|---|
| Research Term Revenue | 18.5M |
| Research Term Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 17.99M | 18.36M | 16.14M | 15.04M | 14.3M | 13.55M | 13.66M | 13.13M | 12.27M | 12.23M | 13.72M | 11.61M | 12.81M | 12.37M | 12.11M | 12.94M | 10.97M | 10.08M | 9.72M | 9.59M | 10.21M | 13M | 13.8M | 12.52M | 11.64M | 10.9M | 12.75M | 9.85M | 8.9M | 8M | 6.89M | 7.57M | 6.67M | 5.85M | 5.18M | 3.94M | 3.65M | 3.22M | 3.75M | 2.86M | 1.91M | 1.88M |
| Selling, General, and Administrative Revenue Growth | -2.00% | +13.76% | +7.27% | +5.22% | +5.51% | -0.84% | +4.08% | +7.04% | +0.25% | -10.85% | +18.22% | -9.35% | +3.49% | +2.15% | -6.41% | +18.01% | +8.84% | +3.69% | +1.35% | -6.03% | -21.48% | -5.86% | +10.24% | +7.59% | +6.78% | -14.53% | +29.50% | +10.60% | +11.30% | +16.18% | -9.03% | +13.56% | +13.97% | +12.83% | +31.63% | +7.80% | +13.62% | -14.15% | +31.07% | +50.03% | +1.11% | n/a |
| Research and Development Revenue | 43.47M | 40.62M | 44.65M | 41.2M | 40.39M | 33.45M | 34.07M | 31.64M | 33.31M | 30.98M | 31.08M | 27.57M | 29.73M | 27.47M | 25.76M | 31.09M | 31.64M | 33.39M | 30.03M | 28.27M | 31.48M | 41.16M | 49.13M | 44.59M | 41.6M | 40.11M | 39.81M | 32.88M | 32.55M | 29.2M | 25.37M | 20.1M | 19.1M | 14.74M | 13.99M | 13.69M | 8.4M | 4.74M | 3.47M | 2.13M | 1.85M | 1.61M |
| Research and Development Revenue Growth | +7.01% | -9.01% | +8.37% | +1.99% | +20.77% | -1.84% | +7.69% | -5.02% | +7.54% | -0.32% | +12.70% | -7.26% | +8.24% | +6.63% | -17.13% | -1.74% | -5.26% | +11.19% | +6.22% | -10.18% | -23.52% | -16.22% | +10.19% | +7.16% | +3.72% | +0.76% | +21.09% | +1.01% | +11.48% | +15.09% | +26.23% | +5.20% | +29.60% | +5.32% | +2.26% | +62.91% | +77.39% | +36.56% | +62.66% | +15.24% | +15.12% | n/a |